Radiofrequency Ablation for the Treatment of Drug-Refractory Symptomatic Paroxysmal Atrial Fibrillation

Please note: All assessments are current as of the review date; however, new evidence that may have been published subsequently is not considered.
Review Date:	June 2, 2010
Recommendation:	After hearing expert testimony and discussion, the CTAF panel discussion leader presented an alternative recommendation. It is recommended that RFA as a treatment for paroxysmal atrial fibrillation refractory to drug therapy meets CTAF criteria 1 through 5 for safety, effectiveness and improvement in health outcomes.
Decision:	Does Meet CTAF Criteria
Full Assessment:	Download (PDF)
History:	February 17, 2010: Radiofrequency Ablation for Treatment of Dysplastic Barrett’s Esophagus

Search Assessments